Product details
Catalog number BNC742300-500
Price for BNC742300-500
Size / count 1x 500 µL
This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e.g. tamoxifen) therapy. This MAb is excellent for staining of formalin-fixed, paraffin-embedded breast carcinomas.Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF740 conjugate, 0.1mg/mL is BNC742300-500.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF740 conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF740 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF740 conjugate, 0.1mg/mL is manufactured by Biotium.
Estimated delivery time for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF740 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for Estrogen Receptor, alpha (Marker of Estrogen Dependence) (rESR1/1935), CF740 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd02ad061270361e1084d6/msds/bnc742300-500.pdf.
This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e.g. tamoxifen) therapy
Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.
Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.
Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.